Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Tuberous Sclerosis 1 (TSC1) (T1149) antibody
| Antigen | Tuberous Sclerosis 1 (TSC1) |
| Synonyms | LAM, TSC, KIAA0243, MGC86987, hamartin, mKIAA0243, TSC1, MGC165718 |
| Binding Site |
Alternatives T1149 |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) |
![]() |
5 references available |
| Catalog no. | ABIN195469 |
| Quantity | 100ug |
| Price | 618.20 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 8 to 11 Business Days |
Additional Information
| Alternative name | TSC1/Hamartin (T1149) |
| Immunogen | The synthetic peptide of a part of Human TSC1/Hamartin (GQLHIMDYNETHHEHS) |
| Format | Affinity-purified |
| Isotype | IgG |
| Description | TSC1 is a tumor-suppressor gene encoding a protein TSC1/Hamartin of about 130 kDa (ref. 1). Loss of its function causes TSC (tuberous sclerosis complex) or angiomyolipoma in human and in an animal model, TSC1 knockout mouse develops a renal tumor (ref. 2). TSC1/Hamartin, a product of TSC1, forms a complex with TSC2/Tuberin (ref. 3), a product of another tumor-suppressor gene TSC2 in cytoplasm (ref. 4). The complex suppresses mTOR activity and regulates cellular growth and division in a insulin signaling pathway (ref. 5). Under the condition of proliferation stimulus, forming of the complex is inhibited, and as a result, suppression to mTOR comes off and it leads to cellular growth and division. |
| Specificity | Crossreactivities with mouse |
Application Details
| Application Notes | This antibody can be stained in formalin fixed paraffin embedded tissues by several Immunohistochemical techniques such as Avidin Biotin Complex (ABC) Method. The optimal dilution is 1 - 5 ?g /mL, however, the dilution rate should be optimized by each laboratories. This antibody can be used for western blotting in concentration of 1 - 5 ?g /mL. |
| Purification | Purified with antigen peptide |
| Buffer | Lyophilized product from 1% BSA in PBS containing 0.05% NaN3 |
| Storage | Lyophilized product, 5 years at 2 – 8 ?. Solution, 2 years at –20 ?. 1.0 mL deionized water will be added to the product (the conc. comes up 100ug/ml) |
| Research Area | Cancer, Diabetes |
| Restrictions | For Research Use only |
Publications
|
"Identification and characterization of the tuberous sclerosis gene on chromosome 16." in: Cell, Vol. 75, Issue 7, pp. 1305-15, 1994 (PubMed).
van Slegtenhorst, de Hoogt, Hermans et al.: "Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34." in: Science (New York, N.Y.), Vol. 277, Issue 5327, pp. 805-8, 1997 (PubMed). Plank, Yeung, Henske: "Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles." in: Cancer research, Vol. 58, Issue 21, pp. 4766-70, 1998 (PubMed). Gao, Pan: "TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth." in: Genes & development, Vol. 15, Issue 11, pp. 1383-92, 2001 (PubMed). Kobayashi, Minowa, Sugitani et al.: "A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 15, pp. 8762-7, 2001 (PubMed). |
|
Alternatives
Alternatives for antigen "Tuberous Sclerosis 1 (TSC1)", type "Antibodies"




Alternatives